Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sergei V. Tillib"'
Autor:
Clarissa Bauernfeind, Ines Zettl, Tatiana Ivanova, Oksana Goryainova, Anna Marianne Weijler, Barbara Pranz, Anja Drescher, Margarete Focke-Tejkl, Tea Pavkov-Keller, Julia Eckl-Dorna, Sergei V. Tillib, Sabine Flicker
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundAround 20% of the population in Northern and Central Europe is affected by birch pollen allergy, with the major birch pollen allergen Bet v 1 as the main elicitor of allergic reactions. Together with its cross-reactive allergens from relate
Externí odkaz:
https://doaj.org/article/8f1750e1bb4947d6b93bb9b026939217
Autor:
Ekaterina A. Koroleva, Oksana S. Goryainova, Tatiana I. Ivanova, Marina V. Rutovskaya, Naylia A. Zigangirova, Sergei V. Tillib
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 4, p 2047 (2024)
The development of new approaches and drugs for effective control of the chronic and complicated forms of urogenital chlamydia caused by Chlamydia trachomatis, which is suspected to be one of the main causes of infertility in both women and men, is a
Externí odkaz:
https://doaj.org/article/6bd4385b729e49e29a4d232766ad237a
Autor:
Ines Zettl, Tatiana Ivanova, Mohammed Zghaebi, Marina V. Rutovskaya, Isabella Ellinger, Oksana Goryainova, Jessica Kollárová, Sergio Villazala-Merino, Christian Lupinek, Christina Weichwald, Anja Drescher, Julia Eckl-Dorna, Sergei V. Tillib, Sabine Flicker
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The nasal cavity is an important site of allergen entry. Hence, it represents an organ where trans-epithelial allergen penetration and subsequent IgE-mediated allergic inflammation can potentially be inhibited. Intercellular adhesion molecule 1 (ICAM
Externí odkaz:
https://doaj.org/article/921e0cd4744a44a5a366ba6a25eee897
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In the last decade single domain antibodies (nanobodies, VHH) qualified through their unique characteristics have emerged as accepted and even advantageous alternative to conventional antibodies and have shown great potential as diagnostic and therap
Externí odkaz:
https://doaj.org/article/af3353d6101f414e895cb560224fa66c
Autor:
Aliya K. Stanova, Varvara A. Ryabkova, Sergei V. Tillib, Vladimir J. Utekhin, Leonid P. Churilov, Yehuda Shoenfeld
Publikováno v:
Antibodies, Vol 9, Iss 2, p 19 (2020)
Anti-idiotypic antibodies (anti-IDs) were discovered at the very beginning of the 20th century and have attracted attention of researchers for many years. Nowadays, there are five known types of anti-IDs: α, β, γ, ε, and δ. Due to the ability of
Externí odkaz:
https://doaj.org/article/4b54c98cd69c4081b002cee01c3af0d7
Autor:
Maxim A. Nosenko, Kamar-Sulu N. Atretkhany, Vladislav V. Mokhonov, Grigory A. Efimov, Andrey A. Kruglov, Sergei V. Tillib, Marina S. Drutskaya, Sergei A. Nedospasov
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Proinflammatory cytokines, such as TNF, IL-6, and IL-1, play pathogenic roles in multiple diseases and are attractive targets for biologic drugs. Because proinflammatory cytokines possess non-redundant protective and immunoregulatory functions, their
Externí odkaz:
https://doaj.org/article/937fbf19f2fe463aa54a9611e61ef54d
Autor:
Ekaterina N. Gorshkova, Grigory A. Efimov, Ksenia D. Ermakova, Ekaterina A. Vasilenko, Diana V. Yuzhakova, Marina V. Shirmanova, Vladislav V. Mokhonov, Sergei V. Tillib, Sergei A. Nedospasov, Irina V. Astrakhantseva
Publikováno v:
Antibodies, Vol 7, Iss 4, p 43 (2018)
Upregulation of the expression of tumor necrosis factor (TNF-α, TNF) has a significant role in the development of autoimmune diseases. The fluorescent antibodies binding TNF may be used for personalized therapy of TNF-dependent diseases as a tool to
Externí odkaz:
https://doaj.org/article/c932b57ac3ec4c239f2f52d04e923ce1
Autor:
Tatiana I. Ivanova, Ilya D. Klabukov, Ludmila I. Krikunova, Marina V. Poluektova, Natalia I. Sychenkova, Vera A. Khorokhorina, Nikolay V. Vorobyev, Margarita Ya. Gaas, Denis S. Baranovskii, Oksana S. Goryainova, Anastasiya M. Sachko, Peter V. Shegay, Andrey D. Kaprin, Sergei V. Tillib
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 24; Pages: 7377
(1) Background: There are no reliable and widely available markers of functional iron deficiency (FID) in cancer. The aim of the study was to evaluate the role of transferrin (Tf) as a marker of cancer of the ovary (CrO) and related FID. (2) Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e177179a656ef202134159c0a1a010c
https://pubmed.ncbi.nlm.nih.gov/36555993
https://pubmed.ncbi.nlm.nih.gov/36555993
Publikováno v:
Analytical Biochemistry; May 1, 2001, Vol. 292 Issue: 1 p155-160, 6p